{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:15:59Z","timestamp":1789150559275,"version":"build-2803163510"},"reference-count":35,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,1,1]]},"DOI":"10.5551\/jat.63369","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T22:13:12Z","timestamp":1646431992000},"page":"39-55","source":"Crossref","is-referenced-by-count":9,"title":["P2Y12 Reaction Units and Clinical Outcomes in Acute Large Artery Atherosclerotic Stroke: A Multicenter Prospective Study"],"prefix":"10.5551","volume":"30","author":[{"given":"Kazuki","family":"Fukuma","sequence":"first","affiliation":[{"name":"Department of Neurology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamagami","sequence":"additional","affiliation":[{"name":"Division of Stroke Care Unit, National Cerebral and Cardiovascular Center"},{"name":"Department of Stroke Neurology, National Hospital Organization Osaka National Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kokame","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Departments of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Nakaoku","sequence":"additional","affiliation":[{"name":"Departments of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Center for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikito","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kamiyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nakamura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Gifu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Itabashi","sequence":"additional","affiliation":[{"name":"Department of Stroke Neurology, Kohnan Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Furui","sequence":"additional","affiliation":[{"name":"Department of Stroke Neurology, Kohnan Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Okayama Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ezura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Sendai Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Todo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hashikawa","sequence":"additional","affiliation":[{"name":"Department of Stroke Neurology, National Hospital Organization Osaka National Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Nagatsuka","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV and Tirschwell DL: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke, 2019; 50: e344-e418","DOI":"10.1161\/STR.0000000000000211"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Savi P, Herbert JM, Pflieger AM, Dol F, Delebassee D, Combalbert J, Defreyn G and Maffrand JP: Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel. Biochem Pharmacol, 1992; 44: 527-532","DOI":"10.1016\/0006-2952(92)90445-O"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bauer T, Bouman HJ, van Werkum JW, Ford NF, ten Berg JM and Taubert D: Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. BMJ, 2011; 343: d4588","DOI":"10.1136\/bmj.d4588"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Banerjee C and Chimowitz MI: Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res, 2017; 120: 502-513","DOI":"10.1161\/CIRCRESAHA.116.308441"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F, Carolei A and Sacco S: Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes: A Systematic Review and Meta-Analysis. Stroke, 2018; 49: 814-819","DOI":"10.1161\/STROKEAHA.117.020031"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Pan Y, Chen W, Xu Y, Yi X, Han Y, Yang Q, Li X, Huang L, Johnston SC, Zhao X, Liu L, Zhang Q, Wang G, Wang Y and Wang Y: Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis. Circulation, 2017; 135: 21-33","DOI":"10.1161\/CIRCULATIONAHA.116.024913"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Han Y, Lv HH, Liu X, Dong Q, Yang XL, Li SX, Wu S, Jiang JM, Luo Z, Zhu DS, Zhang Y, Zheng Y, Guan YT and Xu JF: Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response. CNS Neurosci Ther, 2015; 21: 692-697","DOI":"10.1111\/cns.12426"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) McDonough CW, McClure LA, Mitchell BD, Gong Y, Horenstein RB, Lewis JP, Field TS, Talbert RL, Benavente OR, Johnson JA and Shuldiner AR: CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study. J Am Heart Assoc, 2015; 4: e001652","DOI":"10.1161\/JAHA.114.001652"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hoh BL, Gong Y, McDonough CW, Waters MF, Royster AJ, Sheehan TO, Burkley B, Langaee TY, Mocco J, Zuckerman SL, Mummareddy N, Stephens ML, 2nd, Ingram C, Shaffer CM, Denny JC, Brilliant MH, Kitchner TE, Linneman JG, Roden DM and Johnson JA: CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease. J Neurosurg, 2016; 124: 1746-1751","DOI":"10.3171\/2015.6.JNS15795"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tanaka T, Yamagami H, Ihara M, Miyata T, Miyata S, Hamasaki T, Amano S, Fukuma K, Yamamoto H, Nakagawara J, Furui E, Uchiyama S, Hyun B, Yamamoto Y, Manabe Y, Ito Y, Fukunaga R, Abumiya T, Yasaka M, Kitagawa K, Toyoda K and Nagatsuka K: Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke. Circ J, 2019; 83: 1385-1393","DOI":"10.1253\/circj.CJ-18-1386"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Jia DM, Chen ZB, Zhang MJ, Yang WJ, Jin JL, Xia YQ, Zhang CL, Shao Y, Chen C and Xu Y: CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China. Stroke, 2013; 44: 1717-1719","DOI":"10.1161\/STROKEAHA.113.000823"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zhang S, Lai X, Li W, Xiong Z, Xu A, Xu A and Huang L: VASP phosphorylation and genetic polymorphism for clopidogrel resistance in Chinese patients with non-cardioembolic ischemic stroke. Thromb Res, 2014; 134: 1272-1277","DOI":"10.1016\/j.thromres.2014.10.001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Qiu LN, Sun Y, Wang L, Han RF, Xia XS, Liu J and Li X: Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. Eur J Pharmacol, 2015; 747: 29-35","DOI":"10.1016\/j.ejphar.2014.11.037"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tomek A, Mat\u2019oska V, Frydmanova A, Magerova H, Sramek M, Paulasova-Schwabova J, Ruzickova T, Jansky P, Sarbochova I, Hadacova I, Kaplan V, Lacinova Z, Taborsky L and Serebruany V: Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors. Am J Ther, 2018; 25: e202-e212","DOI":"10.1097\/MJT.0000000000000416"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yi X, Lin J, Wang Y, Zhou Q, Wang C, Cheng W and Chi L: Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke. J Atheroscler Thromb, 2016; 23: 1188-1200","DOI":"10.5551\/jat.33290"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Jeong TD, Kim SM, Kim HJ, Lee W, Kwon SU, Min WK, Kang DW and Chun S: CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel. J Stroke Cerebrovasc Dis, 2015; 24: 440-446","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sun W, Li Y, Li J, Zhang Z, Zhu W, Liu W, Cai Q, Wang X, Cao L, Bai W, Fan X, Ma M, Guo R, Liu X and Xu G: Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel. Platelets, 2015; 26: 558-562","DOI":"10.3109\/09537104.2014.953044"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang Y, Cai H, Zhou G, Zhang Z and Liu X: Effect of CYP2C19<sup>\uff0a<\/sup>2 and <sup>\uff0a<\/sup>3 on clinical outcome in ischemic stroke patients treated with clopidogrel. J Neurol Sci, 2016; 369: 216-219","DOI":"10.1016\/j.jns.2016.08.025"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wang Y, Zhao X, Lin J, Li H, Johnston SC, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, Wang Y and investigators C: Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack. JAMA, 2016; 316: 70-78","DOI":"10.1001\/jama.2016.8662"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yi X, Lin J, Zhou J, Wang Y, Huang R and Wang C: The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke. Oncotarget, 2018; 9: 17725-17734","DOI":"10.18632\/oncotarget.24877"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hulot JS, Bura A, Villard E, Azizi M, Remones V, Goyenvalle C, Aiach M, Lechat P and Gaussem P: Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood, 2006; 108: 2244-2247","DOI":"10.1182\/blood-2006-04-013052"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L and Ingelman-Sundberg M: A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther, 2006; 79: 103-113","DOI":"10.1016\/j.clpt.2005.10.002"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Scott SA, Sangkuhl K, Stein CM, Hulot JS, Mega JL, Roden DM, Klein TE, Sabatine MS, Johnson JA, Shuldiner AR and Clinical Pharmacogenetics Implementation C: Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther, 2013; 94: 317-323","DOI":"10.1038\/clpt.2013.105"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Fricke-Galindo I, Cespedes-Garro C, Rodrigues-Soares F, Naranjo ME, Delgado A, de Andres F, Lopez-Lopez M, Penas-Lledo E and A LL: Interethnic variation of CYP2C19 alleles, \u2018predicted\u2019 phenotypes and \u2018measured\u2019 metabolic phenotypes across world populations. Pharmacogenomics J, 2016; 16: 113-123","DOI":"10.1038\/tpj.2015.70"},{"key":"25","unstructured":"25) Oppenheim C, Stanescu R, Dormont D, Crozier S, Marro B, Samson Y, Rancurel G and Marsault C: False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol, 2000; 21: 1434-1440"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kaikita K, Yoshimura H, Ishii M, Kudoh T, Yamada Y, Yamamoto E, Izumiya Y, Kojima S, Shimomura H, Tsunoda R, Matsui K, Ogawa H, Tsujita K and Investigators C-G: Tailored Adjunctive Cilostazol Therapy Based on CYP2C19 Genotyping in Patients With Acute Myocardial Infarction- The CALDERA-GENE Study. Circ J, 2018; 82: 1517-1525","DOI":"10.1253\/circj.CJ-18-0197"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Suh JW, Cha MJ, Lee SP, Chae IH, Bae JH, Kwon TG, Bae JW, Cho MC, Rha SW and Kim HS: Relationship between statin type and responsiveness to clopidogrel in patients treated with percutaneous coronary intervention: a subgroup analysis of the CILON-T trial. J Atheroscler Thromb, 2014; 21: 140-150","DOI":"10.5551\/jat.19265"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Saiz-Rodriguez M, Romero-Palacian D, Villalobos-Vilda C, Caniego JL, Belmonte C, Koller D, Barcena E, Talegon M and Abad-Santos F: Influence of CYP2C19 Phenotype on the Effect of Clopidogrel in Patients Undergoing a Percutaneous Neurointervention Procedure. Clin Pharmacol Ther, 2019; 105: 661-671","DOI":"10.1002\/cpt.1067"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Park SH, Kim W, Park CS, Kang WY, Hwang SH and Kim W: A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure. Am J Cardiol, 2009; 104: 1292-1295","DOI":"10.1016\/j.amjcard.2009.06.049"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Giustino G, Kirtane AJ, Genereux P, Baber U, Witzenbichler B, Neumann FJ, Weisz G, Maehara A, Rinaldi MJ, Metzger C, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Jr., Brodie BR, Stuckey TD, Dangas GD, Francese DP, Litherland C, Mehran R and Stone GW: Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. Am J Cardiol, 2016; 117: 1703-1713","DOI":"10.1016\/j.amjcard.2016.03.001"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL, Jr., Parvataneni R, Maehara A, Genereux P, Mehran R and Stone GW: Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: \u201cWindow\u201d Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). JACC Cardiovasc Interv, 2015; 8: 1978-1987","DOI":"10.1016\/j.jcin.2015.08.032"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kim BJ, Kwon JY, Jung JM, Lee DH, Kang DW, Kim JS and Kwon SU: Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting. J Neurosurg, 2014; 121: 891-898","DOI":"10.3171\/2014.6.JNS132448"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Wang Y, Chen W, Lin Y, Meng X, Chen G, Wang Z, Wu J, Wang D, Li J, Cao Y, Xu Y, Zhang G, Li X, Pan Y, Li H, Zhao X, Liu L, Lin J, Dong K, Jing J, Johnston SC, Wang D, Wang Y and Group PPS: Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ, 2019; 365: l2211","DOI":"10.1136\/bmj.l2211"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, Jia J, Dong Q, Xu A, Zeng J, Li Y, Wang Z, Xia H, Johnston SC and Investigators C: Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med, 2013; 369: 11-19","DOI":"10.1056\/NEJMoa1215340"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Okazaki S, Morimoto T, Kamatani Y, Kamimura T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Washida K, Saito S, Takahashi A, Hirata M, Matsuda K, Mochizuki H, Chong M, Pare G, O\u2019Donnell M, Ago T, Hata J, Ninomiya T, Dichgans M, Debette S, Kubo M, Koizumi A and Ihara M: Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis. Circulation, 2019; 139: 295-298","DOI":"10.1161\/CIRCULATIONAHA.118.038439"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/1\/30_63369\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:49:27Z","timestamp":1715316567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/1\/30_63369\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63369","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]},"article-number":"63369"}}